Global Device Company to Build R&D Center in Pearland, TX
10/12/2011
Headquartered in South Jordan, Utah, Merit develops, manufactures and distributes proprietary disposable medical devices used in interventional and diagnostic procedures (i.e., cardiology, radiology and endoscopy). It serves hospitals worldwide, and employs about 2,300 associates.
The company conducted a multi-state site search before choosing Pearland for its new project. "We wanted to be part of a community that was growing," said Greg Fredde, Merit's VP of government affairs. "This is a location that provides Merit employees easy access to the facility with minimal disruptions. Pearland's investments, infrastructure and retail amenities will also be beneficial to employees."
Pearland Mayor Tom Reid said Merit is the second medical manufacturing facility to choose to locate in Pearland, and follows on the heels of Cardiovascular Systems, Inc. "It has been a long-standing goal of the City to cultivate a broad spectrum of medical-related organizations in our community. Merit's selection of Pearland is a testament to our efforts and willingness to work with businesses interested in investing in our city."
Project Announcements
Australia-Based Aquatic Leisure Technologies Group Plans Opp, Alabama, Manufacturing Operations
12/11/2025
Teradyne Plans Wixom, Michigan, Robotics Operations
12/11/2025
Robinson Plans Altoona, Iowa, Manufacturing Operations
12/11/2025
BioTouch Expands Columbus, Georgia, Operations
12/11/2025
Natrion Plans Erie County, New York, Battery Components Operations
12/11/2025
Czech-Based GZ PrintPak Expands Mount Pleasant, Wisconsin, Manufacturing Operations
12/11/2025
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
First Person: Filter King’s Expansion Playbook
Q3 2025
-
Lead with Facts, Land the Deal
Q3 2025
-
How Canada Stays Competitive
Q3 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
America’s Aerospace Reboot
Q3 2025